PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
Vidal has served as head of the USPTO since being confirmed by the Senate in 2022. She oversaw a budget of $4.2 billion and ...
Moving forward, Bettendorf's youth sports programs and coach-led camps can apply to use trademarked district logos, followed ...
Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...